ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be Established Response

被引：0
|
作者：
Singal, Ashwani K. [1 ]
Bataller, Ramon [2 ]
Ahn, Joseph [3 ]
Kamath, Patrick S. [4 ]
Shah, Vijay H. [4 ]
机构：
[1] Univ Alabama Birmingham, Div Gastroenterol & Hepatol, Birmingham, AL USA
[2] Univ Pittsburgh, Med Ctr, Div Gastroenterol & Hepatol, Pittsburgh, PA USA
[3] Oregon Hlth & Sci Univ, Div Gastroenterol & Hepatol, Portland, OR 97201 USA
[4] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷 / 01期
关键词：
MODELS;
D O I：
10.14309/ajg.0000000000000073
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [21] Non-Alcoholic Fatty Liver Disease Epidemiology, Clinical Course, Investigation, and Treatment
    Weiss, Johannes
    Rau, Monika
    Geier, Andreas
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2014, 111 (26): : 447 - U22
  • [22] Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease
    Lee, Kwang Seob
    Cho, Yongin
    Kim, Hongkyung
    Hwang, Hyunkyeong
    Cho, Jin Won
    Lee, Yong-ho
    Lee, Sang-Guk
    BIOMEDICINES, 2022, 10 (06)
  • [23] Obstructive Sleep Apnea and CPAP Treatment Response in Patients with Non Alcoholic Fatty Liver Disease
    Hui, D. S.
    Ng, S.
    Wong, G.
    Chu, W.
    Ko, F.
    To, K.
    Chan, K.
    Yip, W.
    Ngai, J.
    Lo, L.
    Wong, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] Clinical advantages and efficacy of sleeve gastrectomy in the treatment of non-alcoholic fatty liver disease
    Wang, Wenbo
    Cao, Yaoquan
    Zhu, Liyong
    HEPATOBILIARY SURGERY AND NUTRITION, 2025,
  • [25] Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis
    Xiong, Shi-Ying
    Wu, Gui-Sheng
    Li, Chun
    Ma, Wenzhe
    Luo, Huai-Rong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [26] Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis
    Athyros, Vasilios G.
    Katsiki, Niki
    Mikhailidis, Dimitri P.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (04)
  • [27] Tuberculous peritonitis in chronic liver disease: Clinical features and response to treatment
    AlAmri, SM
    AlHumayed, SM
    AlRashed, RS
    AlMofleh, IA
    Ayoola, A
    AlAska, A
    ANNALS OF SAUDI MEDICINE, 1996, 16 (02) : 162 - 165
  • [28] The role of gut microbiota in clinical complications, disease severity, and treatment response in severe alcoholic hepatitis
    Cyriac Abby Philips
    Philip Augustine
    Karthik Ganesan
    Shatakshi Ranade
    Varun Chopra
    Kunal Patil
    Sonie Shende
    Rizwan Ahamed
    Sandeep Kumbar
    Sasidharan Rajesh
    Tom George
    Meera Mohanan
    Narain Mohan
    Nikhil Phadke
    Mridula Rani
    Arjun Narayanan
    Suchetha M. Jagan
    Indian Journal of Gastroenterology, 2022, 41 : 37 - 51
  • [29] The role of gut microbiota in clinical complications, disease severity, and treatment response in severe alcoholic hepatitis
    Philips, Cyriac Abby
    Augustine, Philip
    Ganesan, Karthik
    Ranade, Shatakshi
    Chopra, Varun
    Patil, Kunal
    Shende, Sonie
    Ahamed, Rizwan
    Kumbar, Sandeep
    Rajesh, Sasidharan
    George, Tom
    Mohanan, Meera
    Mohan, Narain
    Phadke, Nikhil
    Rani, Mridula
    Narayanan, Arjun
    Jagan, Suchetha M.
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (01) : 37 - 51
  • [30] Polyphenols in the prevention and treatment of non-alcoholic fatty liver disease: An update of preclinical and clinical studies
    Bayram, Hatice Merve
    Majoo, Fuzail Mohammed
    Ozturkcan, Arda
    CLINICAL NUTRITION ESPEN, 2021, 44 : 1 - 14
12345